116 related articles for article (PubMed ID: 27036631)
1. Brachytherapy improves survival in primary vaginal cancer.
Orton A; Boothe D; Williams N; Buchmiller T; Huang YJ; Suneja G; Poppe M; Gaffney D
Gynecol Oncol; 2016 Jun; 141(3):501-506. PubMed ID: 27036631
[TBL] [Abstract][Full Text] [Related]
2. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
[TBL] [Abstract][Full Text] [Related]
3. Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based Analysis.
Acharya S; Perkins SM; DeWees T; Fischer-Valuck BW; Mutch DG; Powell MA; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):649-57. PubMed ID: 26461007
[TBL] [Abstract][Full Text] [Related]
4. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
Bingham B; Orton A; Boothe D; Stoddard G; Huang YJ; Gaffney DK; Poppe MM
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1040-1050. PubMed ID: 28332987
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy alone for invasive vaginal cancer: outcome with intracavitary high dose rate brachytherapy versus conventional low dose rate brachytherapy.
Kucera H; Mock U; Knocke TH; Kucera E; Pötter R
Acta Obstet Gynecol Scand; 2001 Apr; 80(4):355-60. PubMed ID: 11264612
[TBL] [Abstract][Full Text] [Related]
6. Trends in the utilization of brachytherapy in cervical cancer in the United States.
Han K; Milosevic M; Fyles A; Pintilie M; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):111-9. PubMed ID: 23849695
[TBL] [Abstract][Full Text] [Related]
7. Patterns of care with brachytherapy for cervical cancer.
Bagshaw HP; Pappas LM; Kepka DL; Tward JD; Gaffney DK
Int J Gynecol Cancer; 2014 Nov; 24(9):1659-64. PubMed ID: 25251463
[TBL] [Abstract][Full Text] [Related]
8. Comparison of external beam radiation therapy and radioactive implants in the management of nonmetastatic oral squamous cell cancer: an analysis of the surveillance epidemiology and end results database.
Agaku IT; Akinyele AO
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jan; 115(1):38-45. PubMed ID: 23021918
[TBL] [Abstract][Full Text] [Related]
9. Patterns of care and brachytherapy boost utilization for vaginal cancer in the United States.
Rajagopalan MS; Xu KM; Lin J; Hansen K; Sukumvanich P; Krivak TC; Kelley JL; Beriwal S
Pract Radiat Oncol; 2015; 5(1):56-61. PubMed ID: 25413431
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Definitive Radiation Therapy for Primary Vaginal Carcinoma.
Greenwalt JC; Amdur RJ; Morris CG; Morgan LS; Castagno J; Markham MJ; Rich S; Yeung AR
Am J Clin Oncol; 2015 Dec; 38(6):583-7. PubMed ID: 24136141
[TBL] [Abstract][Full Text] [Related]
11. Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?
Crosby MA; Tward JD; Szabo A; Lee CM; Gaffney DK
Am J Clin Oncol; 2010 Aug; 33(4):364-9. PubMed ID: 20689365
[TBL] [Abstract][Full Text] [Related]
12. Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancer.
Jackson MW; Amini A; Jones BL; Kavanagh B; Maroni P; Frank SJ; Mahmood U; Kudchadker RJ; Pugh TJ
Brachytherapy; 2017; 16(4):790-796. PubMed ID: 28442277
[TBL] [Abstract][Full Text] [Related]
13. Patterns of care and impact of brachytherapy boost utilization for squamous cell carcinoma of the base of tongue in a large, national cohort.
Lee A; Givi B; Wu SP; Tam MM; Gerber NK; Hu KS; Han P; Schreiber D
Brachytherapy; 2017; 16(6):1205-1212. PubMed ID: 28943128
[TBL] [Abstract][Full Text] [Related]
14. The "decay" of brachytherapy use in tumors of the oral cavity: A population-based patterns of care and outcomes analysis from 1973 to 2012.
Orton A; Boothe D; Gan M; Monroe MM; Hitchcock YJ; Lloyd S
Brachytherapy; 2016; 15(6):851-858. PubMed ID: 27364872
[TBL] [Abstract][Full Text] [Related]
15. Primary radiotherapy for nonsurgically managed Stage I endometrial cancer: Utilization and impact of brachytherapy.
Gill BS; Chapman BV; Hansen KJ; Sukumvanich P; Beriwal S
Brachytherapy; 2015; 14(3):373-9. PubMed ID: 25600451
[TBL] [Abstract][Full Text] [Related]
16. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration.
Kazumoto T; Kato S; Tabushi K; Kutsutani-Nakamura Y; Mizuno H; Takahashi M; Shiromizu K; Saito Y
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1157-66. PubMed ID: 17459604
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for primary vaginal carcinoma.
Murakami N; Kasamatsu T; Sumi M; Yoshimura R; Takahashi K; Inaba K; Morota M; Mayahara H; Ito Y; Itami J
J Radiat Res; 2013 Sep; 54(5):931-7. PubMed ID: 23559599
[TBL] [Abstract][Full Text] [Related]
18. Impact of radiotherapy modalities on outcomes in the adjuvant management of uterine carcinosarcoma: A National Cancer Database analysis.
Stokes WA; Jones BL; Schefter TE; Fisher CM
Brachytherapy; 2018; 17(1):194-200. PubMed ID: 29097136
[TBL] [Abstract][Full Text] [Related]
19. [Management of vaginal carcinoma in patients over 70 years old: advantage of a radiotherapy-brachytherapy association].
Moncharmont C; Levy A; Guy JB; Auberdiac P; Robles A; Malkoun N; Chargari C; Pacaut C; Jacquin JP; Chauleur C; de Laroche G; Magné N
Presse Med; 2013 Oct; 42(10):e371-6. PubMed ID: 23969306
[TBL] [Abstract][Full Text] [Related]
20. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
